Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heska Corp (NASDAQ:HSKA)

107.76
Delayed Data
As of 1:48pm ET
 +0.18 / +0.17%
Today’s Change
26.26
Today|||52-Week Range
109.18
+50.50%
Year-to-Date
CytRx Gets Clarity from FDA for Aldoxorubicin NDA, Shares Up
Apr 20 / Zacks.com - Paid Partner Content
Bristol-Myers and Nordic Ink Biomarker Collaboration Deal
Apr 18 / Zacks.com - Paid Partner Content
Zacks.com featured highlights: Heska, Zeltiq Aesthetics, YY, MaxLinear and Teradyne
Apr 20 / Zacks.com - Paid Partner Content
Rigel Pharmaceuticals Files NDA for Thrombocytopenia Drug
Apr 18 / Zacks.com - Paid Partner Content
Ultragenyx's Hypophosphatemia Drug Succeeds in Phase III
Apr 19 / Zacks.com - Paid Partner Content
Roche's Hemophilia A Drug Positive in Second Phase III Study
Apr 17 / Zacks.com - Paid Partner Content
Arena Pharma (ARNA) Down After Underwritten Public Offering
Apr 19 / Zacks.com - Paid Partner Content
Eli Lilly's Rheumatoid Arthritis Drug Gets CRL in the U.S.
Apr 17 / Zacks.com - Paid Partner Content
Create an Efficient Portfolio with 5 Top Stocks
Apr 19 / Zacks.com - Paid Partner Content
Biogen to License Alzheimer Candidate from Bristol-Myers
Apr 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close107.58
Today’s open107.58
Day’s range106.50 - 109.18
Volume42,277
Average volume (3 months)89,008
Market cap$761.2M
Dividend yield0.37%
Data as of 1:48pm ET, 04/26/2017

Growth & Valuation

Earnings growth (last year)+93.24%
Earnings growth (this year)+18.88%
Earnings growth (next 5 years)+21.40%
Revenue growth (last year)+24.37%
P/E ratio75.4
Price/Sales4.05
Price/Book8.69

Competitors

 Today’s
change
Today’s
% change
ACRSAclaris Therapeutics...-0.19-0.65%
INSYINSYS Therapeutics I...+0.42+3.96%
MGNXMacroGenics Inc+0.16+0.74%
ACORAcorda Therapeutics ...-0.27-1.67%
Data as of 2:03pm ET, 04/26/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)$0.29
Annual revenue (last year)$130.1M
Annual profit (last year)$10.5M
Net profit margin8.08%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Kevin S. Wilson
Secretary, Chief Operating &
Strategist Officer
Jason A. Napolitano
Corporate headquarters
Loveland, Colorado

Forecasts


Search for Jobs